The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Open accessAbstract
BACKGROUND: Helicobacter pylori is one of the most prevalent global pathogens and can lead to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and gastric carcinoma. AIM: To review recent trends in H. pylori antibiotic resistance rates, and to discuss diagnostics and treatment paradigms. METHODS: A PubMed literature search using the following keywords: Helicobacter pylori, antibiotic resistance, clarithromycin, levofloxacin, metronidazole, prevalence, susceptibility testing. RESULTS: The prevalence of bacterial antibiotic resistance is regionally variable and appears to be markedly increasing with time in many countries. Concordantly, the antimicrobial eradication rate of H. pylori has been declining globally. In particular, clarithromycin resistance has been rapidly increasing in many countries over the past decade, with rates as high as approximately 30% in Japan and Italy, 50% in China and 40% in Turkey; whereas resistance rates are much lower in Sweden and Taiwan, at approximately 15%; there are limited data in the USA. Other antibiotics show similar trends, although less pronounced. CONCLUSIONS: Since the choice of empiric therapies should be predicated on accurate information regarding antibiotic resistance rates, there is a critical need for determination of current rates at a local scale, and perhaps in individual patients. Such information would not only guide selection of appropriate empiric antibiotic therapy but also inform the development of better methods to identify H. pylori antibiotic resistance at diagnosis. Patient-specific tailoring of effective antibiotic treatment strategies may lead to reduced treatment failures and less antibiotic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Kyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,244
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Helicobacter Pylori: Epidemiology and Routes of Transmission
Brown, L. M. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018040 · Cited by 1,137
Helicobacter pylori treatment in the era of increasing antibiotic resistance
Graham, D. Y., & Fischbach, L. (2010) · Gut · doi:10.1136/gut.2009.192757 · Cited by 1,028
H pylori antibiotic resistance: prevalence, importance, and advances in testing
Mégraud, F. (2004) · Gut · doi:10.1136/gut.2003.022111 · Cited by 955
Helicobacter pylori persistence: biology and disease
Blaser, M. J., & Atherton, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420925 · Cited by 948
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
McColl, K. E. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001110 · Cited by 773
Helicobacter pylori Detection and Antimicrobial Susceptibility Testing
Mégraud, F., & Lehours, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-06 · Cited by 725
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
World Gastroenterology Organisation Global Guideline: Constipation—A Global Perspective
Lindberg, G., Hamid, S. S., Malfertheiner, P., Thomsen, O. O., Fernandez, L. B., Garisch, J., Thomson, A., Goh, K.-L., Tandon, R., Fedail, S., et al. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31820fb914 · Cited by 539
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
(2012) · PubMed Central · Cited by 502
Guidelines for the Management of Dyspepsia
Talley, N. J., Vakil, N., & the Practice Parameters Committee of the American College of Gastroenterology (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00225.x · Cited by 489
Worldwide H. pylori antibiotic resistance: a systematic review.
Francesco, V. D., Giorgio, F., Hassan, C., et al. (2010) · PubMed · Cited by 480
Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
Graham, D. Y. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.040 · Cited by 454
Characteristics of gastric cancer in Asia
Rahman, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4483 · Cited by 404
New concepts of resistance in the treatment of Helicobacter pylori infections
Graham, D. Y., & Shiotani, A. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1138 · Cited by 359
Goodwin, A., Kersulyte, D., Sisson, G., Veldhuyzen van Zanten, S. J. O., Berg, D. E., & Hoffman, P. S. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00806.x · Cited by 353
Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
Graham, D. Y., Lee, Y., & Wu, M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.028 · Cited by 347
World Gastroenterology Organisation Global Guideline: Helicobacter pylori in Developing Countries
(2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31820fb8f6 · Cited by 315
Epidemiology of Helicobacter pylori infection and gastric cancer in Asia
Fock, K. M., & Ang, T. L. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06188.x · Cited by 304
Seroprevalence of Helicobacter pylori in South Korea
Yim, J. Y., Kim, N., Choi, S. H., Kim, Y. S., Cho, K. R., Kim, S. S., Seo, G. S., Kim, H. U., Baik, G. H., Sin, C. S., et al. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00504.x · Cited by 283
Gatta, L., Vakil, N., Vaira, D., & Scarpignato, C. (2013) · BMJ · doi:10.1136/bmj.f4587 · Cited by 272
Lim, S. H., Kwon, J.-W., Kim, N., Kim, G. H., Kang, J. M., Park, M. J., Yim, J. Y., Kim, H. U., Baik, G. H., Seo, G. S., et al. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-104 · Cited by 249
Wu, D., Hsu, P., Wu, J., Opekun, A. R., Kuo, C., Wu, I. –., Wang, S. S. W., Chen, A., Hung, W., & Graham, D. Y. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.09.030 · Cited by 245
Meyer, J. M., Silliman, N. P., Wang, W., Siepman, N. Y., Sugg, J. E., Morris, D., Zhang, J., Bhattacharyya, H., King, E. C., & Hopkins, R. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00008 · Cited by 226
Duck, W. M., Sobel, J., Pruckler, J. M., Song, Q., Swerdlow, D. L., Friedman, C. R., Sulka, A. C., Swaminathan, B., Taylor, T., Hoekstra, M., et al. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.030744 · Cited by 221
Helicobacter pylori: a poor man's gut pathogen?
Khalifa, M. M., Sharaf, R. R., & Aziz, R. K. (2010) · Gut Pathogens · doi:10.1186/1757-4749-2-2 · Cited by 215
Essa, A. S., Kramer, J. R., Graham, D. Y., & Treiber, G. (2009) · Helicobacter · doi:10.1111/j.1523-5378.2009.00671.x · Cited by 215
Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail
Gisbert, J. P., & Pajares, J. M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01276.x · Cited by 201
Extragastric Manifestations of Helicobacter pylori Infection
Banić, M., Franceschi, F., Babić, Z., & Gasbarrini, A. (2012) · Helicobacter · doi:10.1111/j.1523-5378.2012.00983.x · Cited by 200
McMahon, B. J., Hennessy, T. W., Bensler, J. M., Bruden, D. L., Parkinson, A. J., Morris, J. M., Reasonover, A. L., Hurlburt, D. A., Bruce, M. G., Sacco, F., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00008 · Cited by 198
Schabereiter-Gurtner, C., Hirschl, A. M., Dragosics, B., Hufnagl, P., Puz, S., Kovách, Z., Rotter, M., & Makristathis, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4512-4518.2004 · Cited by 193
Regular review: Treatment of Helicobacter pylori infection
de Boer, W. A. (2000) · BMJ · doi:10.1136/bmj.320.7226.31 · Cited by 186
Hsu, P., Wu, D., Wu, J., & Graham, D. Y. (2011) · Helicobacter · doi:10.1111/j.1523-5378.2011.00828.x · Cited by 180
Rifampin and Rifabutin Resistance Mechanism in Helicobacter pylori
Heep, M., Beck, D., Bayerdörffer, E., & Lehn, N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1497 · Cited by 180
Stender, H., Fiandaca, M., Hyldig-Nielsen, J. J., & Coull, J. (2002) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00340-2 · Cited by 177
Gisbert, J. P., González, L., Calvet, X., García, N., López, T., Roqué, M., Gabriel, R., & Pajares, J. M. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00844.x · Cited by 175
Osato, M. S., Reddy, R., Reddy, S. G., Penland, R. L., Malaty, H. M., & Graham, D. Y. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1217 · Cited by 172
Grad, Y. H., Lipsitch, M., & Aiello, A. E. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr288 · Cited by 168
Kim, J. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.459 · Cited by 165
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans
Shiota, S., Reddy, R., Alsarraj, A., El‐Serag, H. B., & Graham, D. Y. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.02.005 · Cited by 163
Kobayashi, I., Murakami, K., Kato, M., Kato, S., Azuma, T., Takahashi, S., Uemura, N., Katsuyama, T., Fukuda, Y., Haruma, K., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00740-07 · Cited by 159
Fujisawa, T., Kumagai, T., Akamatsu, T., Kiyosawa, K., & Matsunaga, Y. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00339-1 · Cited by 153
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Sugimoto, M., Furuta, T., Shirai, N., Kodaira, C., Nishino, M., Ikuma, M., Ishizaki, T., & Hishida, A. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00508.x · Cited by 150
van Doorn, L., Glupczynski, Y., Kusters, J. G., Mégraud, F., Midolo, P. D., Maggi-Solcà, N., Queiroz, D. M. M., Nouhan, N., Stet, E., & Quint, W. G. V. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1500-1504.2001 · Cited by 148
Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan
Miyachi, H., Miki, I., Aoyama, N., Shirasaka, D., Matsumoto, Y. M., Toyoda, M., Mitani, T., Morita, Y., Tamura, T., Kinoshita, S., et al. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00415.x · Cited by 142
Tankovic, J., Lascols, C., Sculo, Q., Petit, J., & Soussy, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3942-3944.2003 · Cited by 141
Hwang, T. J., Kim, N., Kim, H. B., Lee, B. H., Nam, R. H., Park, J. H., Lee, M. K., Park, Y. S., Lee, D. H., Jung, H. C., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d04592 · Cited by 140
Self-citationZhang, Y.-X., Zhou, L.-Y., Song, Z.-Q., Zhang, J.-Z., He, L.-H., & Ding, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i9.2786 · Cited by 137
Cabrita, J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.1029 · Cited by 137
16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., de Zoete, M. R., Arents, N. L. A., Kuipers, E. J., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2996-3000.2002 · Cited by 137
Epidemiology of Helicobacter pylori infection and Public Health Implications
Ford, A. C., & Axon, A. T. R. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2010.00779.x · Cited by 134
Debets-Ossenkopp, Y. J., Herscheid, A. J., Pot, R. G. J., Kuipers, E. J., Kusters, J. G., & Vandenbroucke‐Grauls, C. M. J. E. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.511 · Cited by 128
Treatment after failure: the problem of “non-responders”
Huang, J., & Hunt, R. H. (1999) · Gut · doi:10.1136/gut.45.2008.i40 · Cited by 127
Hachem, C. Y., Clarridge, J. E., Reddy, R., et al. (1996) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00252-9 · Cited by 124
Cerqueira, L., Azevedo, N. F., Almeida, C., Jardim, T., Keevil, C. W., & Vieira, M. J. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9101944 · Cited by 115
Metronidazole resistance in Helicobacter pylori
Jenks, P. J., & Edwards, D. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00468-x · Cited by 114
How antibiotic resistances could changeHelicobacter pyloritreatment: A matter of geography?
Ierardi, E., Giorgio, F., Losurdo, G., Leo, A. D., & Principi, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i45.8168 · Cited by 114
Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population
Us, D., & Hasçelik, G. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80169-2 · Cited by 113
Cattoir, V., Nectoux, J., Lascols, C., Deforges, L., Delchier, J., Mégraud, F., Soussy, C., & Cambau, E. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.11.007 · Cited by 110
Realdi, G., Dore, M. P., Piana, A. F., et al. (1999) · Helicobacter · doi:10.1046/j.1523-5378.1999.99002.x · Cited by 108
Gerrits, M. M., Schuijffel, D. F., van Zwet, A. A., Kuipers, E. J., Vandenbroucke‐Grauls, C. M. J. E., & Kusters, J. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2229-2233.2002 · Cited by 103
Kato, M., Yamaoka, Y., Kim, J. J., Reddy, R., Asaka, M., Kashima, K., Osato, M. S., El-Zaatari, F. A., Graham, D. Y., & Kwon, D. H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2214-2216.2000 · Cited by 103
Toracchio, S., & Marzio, L. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00265-2 · Cited by 95
Carothers, J. J., Bruce, M. G., Hennessy, T. W., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/510074 · Cited by 88
A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?
Zullo, A., Hassan, C., Lorenzetti, R., Winn, S., & Morini, S. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00081-1 · Cited by 86
Federico, A., Nardone, G., Gravina, A. G., Iovene, M. R., Miranda, A., Compare, D., Pilloni, A. P., Rocco, A., Ricciardiello, L., Marmo, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.043 · Cited by 83
Helicobacter pylori: from the benign to the malignant
Williams, M. P., & Pounder, R. E. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00657-7 · Cited by 82
Manes, G., Menchise, A., de Nucci, C., & Balzano, A. (2003) · BMJ · doi:10.1136/bmj.326.7399.1118 · Cited by 76
Chang, W., Sheu, B., Cheng, H., Yang, Y., Yang, H., & Wu, J. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05829.x · Cited by 73
Burucoa, C., Garnier, M. J., Silvain, C., & Fauchere, J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-07 · Cited by 70
López-Brea, M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.279 · Cited by 69
Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults
Lee, J. H., Shin, J.-H., Roe, I. H., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1600-1603.2005 · Cited by 67
Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai
Sun, Q.-J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i40.5118 · Cited by 66
She, R. C., Wilson, A. R., & Litwin, C. M. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00149-09 · Cited by 66
Perry‐O'Keefe, H., Stender, H., Broomer, A. J., Oliveira, K. C., Coull, J., & Hyldig‐Nielsen, J. J. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01230.x · Cited by 66
Yang, Y., Sheu, B., Lee, S., Yang, H., & Wu, J. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00317.x · Cited by 58
Okamura, T., Suga, T., Nagaya, T., Arakura, N., Matsumoto, T., Nakayama, Y., & Tanaka, E. (2014) · Helicobacter · doi:10.1111/hel.12124 · Cited by 53
Bernstein, C. N., McKeown, I., Embil, J. M., et al. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026689103952 · Cited by 53
New strategies for Helicobacter pylori eradication
Selgrad, M., & Malfertheiner, P. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.010 · Cited by 50
Boyanova, L., STANCHEVA, I., Spassova, Z., KATZAROV, N., Mitov, I., & Koumanova, R. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-5-415 · Cited by 50
Bruce, M. G., Bruden, D. L., McMahon, B. J., Hennessy, T. W., Reasonover, A. L., Morris, J. M., Hurlburt, D. A., Peters, H. V., Sacco, F. D., Martinez, P., et al. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00462.x · Cited by 46
Antimicrobial Susceptibility of Helicobacter pylori Strains in a Random Adult Swedish Population
Storskrubb, T., Aro, P., Ronkainen, J., Wreiber, K., Nyhlin, H., Bolling‐Sternevald, E., Talley, N. J., Engstrand, L. G., & Agréus, L. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00414.x · Cited by 45
Bruce, M. G., Bruden, D. L., Morris, J. M., Reasonover, A. L., Sacco, F. D., Hurlburt, D. A., Hennessy, T. W., Gove, J. E., Parkinson, A. J., SAHAGUN, G., et al. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814001770 · Cited by 43
Which Therapy for Helicobacter pylori Infection?
Graham, D. Y., & Shiotani, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.012 · Cited by 39
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
Bang, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5252 · Cited by 37
Gotoh, A., Kawakami, Y., Akahane, T., Akamatsu, T., Shimizu, T., Kiyosawa, K., & Katsuyama, T. (1997) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1997.tb01166.x · Cited by 34
Perri, F., Festa, V., Merla, A., Quitadamo, M., Clemente, R., & Andriulli, A. (2002) · Helicobacter · doi:10.1046/j.1083-4389.2002.00066.x · Cited by 30
Unexpected Decrease with Age of Helicobacter pylori Seroprevalence among Swedish Blood Donors
Sörberg, M., Nyrén, O., & Granström, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4038-4042.2003 · Cited by 26
Hiyama, T., Tanaka, S., Masuda, H., Shima, H., KOSE, K., Tuncel, H., Ito, M., Kitadai, Y., Sumii, M., Uemura, N., et al. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03140.x · Cited by 22
Burgos, E. C., Forné, M., Quintana, S., Lite, J., & Garau, J. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72778-x · Cited by 22
Poon, S., Lai, C., Chang, C., Lin, W.-Y., Chang, Y.-C., Wang, H., Lin, P.-H., Lin, H., & Wang, W. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.007 · Cited by 19
Yamamoto, T., Takano, T., Higuchi, W., Nishiyama, A., Taneike, I., Yoshida, K., Kanda, H., & Imamura, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01105-10 · Cited by 6
Cited by
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
Tshibangu-Kabamba, E., & Yamaoka, Y. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00449-x · Cited by 517
Use of microalgae based technology for the removal of antibiotics from wastewater: A review
Leng, L., Wei, L., Xiong, Q., Xu, S., Li, W., Lv, S., Lu, Q., Wan, L., Wen, Z., & Zhou, W. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2019.124680 · Cited by 448
Kuo, Y.-T., Liou, J.-M., El-Omar, E. M., Wu, J.-Y., Leow, A. H. R., Goh, K. L., Das, R., Lu, H., Lin, J.-T., Tu, Y.-K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30219-4 · Cited by 319
Fallone, C. A., Moss, S. F., & Malfertheiner, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.011 · Cited by 286
Metadata
- Authors
- Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2015-12-23
- Volume
- 43
- Issue
- 4
- Pages
- 514-533
- ISSN
- 0269-2813 (ISSN-L)
- OpenAlex
- W2199203801
- Cited by
- 743
- References
- 106
- FWCI
- 44.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.